We're excited to announce that LARVOL will be featured on New Frontiers this January 2025! ?? ?? In this special episode, we’ll explore how our Oncology Data Intelligence empowers pharmaceutical and biotech companies to make strategic, data-driven decisions that fuel innovation. From clinical trial insights to expert opinions, we can’t wait to showcase the impact of our work. ?? We’d love for you to tune in and join us! ?? Access the full press release: https://bit.ly/4d9qkAf Stay tuned for more details! #LARVOL #NewFrontiersTV #Oncology #OncologyData #CancerResearch #CancerData #ComingJanuary2025 #DataInnovation #PressRelease #PlanetTVStudios
LARVOL
IT 服务与咨询
San Francisco,California 11,894 位关注者
Empowering pharma, biotech, and life sciences with customized SaaS and expert intelligence since 2004.
关于我们
Customized intelligence reports and SaaS solutions - We provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Our products include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.
- 网站
-
https://www.larvol.com
LARVOL的外部链接
- 所属行业
- IT 服务与咨询
- 规模
- 51-200 人
- 总部
- San Francisco,California
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Financial analyst monitoring、Scientific Conferences、life sciences、medical conferences和healthcare
产品
OMNI
Business Intelligence (BI) Software
Stay up-to-date with all aspects of your KOL activity. OMNI makes it easy with complete coverage of both on and offline news delivered in real-time to your inbox and our user-friendly online platform.
地点
-
主要
548 Mission St
Suite 44120
US,California,San Francisco,94105
LARVOL员工
-
Bruno Larvol
-
Vincent Guerlavais
Inventor & Drug Hunter, Senior Director Medicinal Chemistry & Drug Discovery
-
Sreedhar Reddy
Vice President - Product Management and Strategy at LARVOL | Building SaaS products for Pharma | Cancer clinical data | KOL tracking | Conferences |…
-
Vinod T.K.
Developer at The Larvol Group
动态
-
Are you heading to San Antonio Breast Cancer Symposium 2024? Our CEO, Bruno Larvol and VP of Oncology, Mark Gramling, will be attending SABCS 2024 from December 10-13 in San Antonio, TX. Don’t miss this opportunity to connect with us and explore how our essential oncology data solutions are transforming research and patient care. Let’s shape the future of oncology together! #LARVOL #SABCS24 #Oncology #CancerResearch #OncologyUpdates #CancerCare #BreastCancer
-
The San Antonio Breast Cancer Symposium (SABCS) 2024 abstracts (including late-breaking!) are live! Get ready to explore the latest in breast cancer research at SABCS 2024 in San Antonio, Texas, December 10-13. LARVOL will be at the conference, showcasing the key oncology data solutions designed to transform research and patient care. Let's connect to uncover insights, spark innovation, and drive impactful collaborations in the fight against cancer. Mark your calendar and meet us there! #LARVOL #SABCS24 #CancerResearch #Oncology #OncologyUpdates #BreastCancer #CancerData #CancerCare
-
Are you ready for the American Society of Hematology 2024? Our CEO, Bruno Larvol, will be attending ASH 2024 in San Diego from December 7-10! He's excited to connect with fellow industry leaders and dive into discussions on the latest advancements in Hematology-Oncology. Let’s shape the future of Hem-Onc together. If you're attending the conference, let us know in the comments or reach out to schedule a meeting! #LARVOL #ASH2024 #Oncology #Hematology #OncologyUpdates #CancerCare #CancerData #CancerResearch
-
Late-breaking abstracts for the American Society of Hematology 2024 are here! Are you ready to dive into groundbreaking cancer research? Join LARVOL at ASH 2024 in San Diego, December 7-10, as we showcase our game-changing oncology data solutions. ?? Whether you're seeking insights, innovation, or impactful collaborations, let's connect and take cancer data intelligence to the next level. ?? See you in San Diego! #LARVOL #ASH24 #Oncology #CancerResearch #CancerData #OncologyUdpates #Hematology
-
The latest episode of the LARVOL Onco Data Podcast is live! Join Mark Gramling and Darko Medin, as they explore Pseudo IPD in Cancer Research and the role of Network Meta-Analysis in oncology. Tune in now: https://bit.ly/3ZlpDQU #LARVOL #Oncology #CancerResearch #CancerData #OncoDataPodcast #MedicalPodcast #NetworkMetaAnalysis
-
In this episode, Mark Gramling is joined by Darko Medin for a dive into the complexities of network meta-analysis in oncology and its integration with pseudo-IPD (Individual Patient Data). The conversation explores how LARVOL’s CLIN platform is advancing data curation to enable comprehensive and predictive analyses in cancer research. Key topics include: ? The use of pseudo-IPD for combining treatment data ? The role of network meta-analysis in comparing multiple treatments simultaneously ? How combining direct and indirect evidence provides valuable insights in oncology Don’t miss out on this discussion on the power of big data and AI for more effective cancer treatment strategies.
LARVOL Onco Data Podcast: Pseudo-IPD and Network Meta-Analysis in Oncology
www.dhirubhai.net
-
?? Episode 8 of the 'LARVOL CLIN - Building In Public' Podcast is now live! Join Bruno Larvol and Kalpana Devi, Director at LARVOL, as they discuss the importance of the Landscape feature in LARVOL CLIN. This function compares main treatments with clinical trial data, offering valuable insights that serve as a guideline in oncology. It provides a comprehensive data table and the emerging data landscape for cancer patients. Tune in now: https://bit.ly/3V2Mwpr With LARVOL CLIN, stay informed and ahead in the fast-evolving world of oncology. Access key insights, stay updated on new developments, and leverage data intelligence to elevate your practice. Discover more: https://bit.ly/4da5h1k #LARVOL #Oncology #CancerResearch #MedicalOncology #CancerTreatment #OncologyUpdates #MedicalPodcast #LARVOLCLIN
-
Ahead of the American Society of Hematology 2024, we’ve highlighted the top diseases from the field of oncology. Save the date! We will be at ASH 2024 in San Diego, from December 7-10, showcasing innovative cancer data solutions. With LARVOL CLIN, you’ll remain at the cutting edge of the evolving oncology landscape. Access critical insights that drive your practice and stay ahead of industry trends. Don’t miss out—connect with us and stay informed ?? https://bit.ly/4da5h1k Connect with our leading oncology partners from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala| Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates